Navigation Links
CEL-SCI Corporation Releases Letter to Shareholders
Date:2/20/2009

VIENNA, Va., Feb. 20 /PRNewswire-FirstCall/ -- The following letter is being released by CEL-SCI Corporation (NYSE Alternext US: CVM) to its shareholders:

Dear Fellow Shareholders:

I am writing today to provide you with a review of 2008 as well as to update you on our plans for dealing with the current financial downturn. In looking back at the last year, I see a year of meaningful accomplishments which put CEL-SCI in a valuable position, and among a very select group of companies that have a completely novel medicine with blockbuster potential ready to go into a Phase III clinical trial.

Key Company highlights of 2008:

  • We extended our Multikine licensing agreement with Orient EuroPharma of Taiwan (a leading pharmaceutical company in Taiwan) to cover additional countries in the Far East. Orient EuroPharma will also participate in and pay for part of our Phase III trial.

  • At the end of 2008 we took delivery of the Multikine manufacturing facility in Baltimore. This facility will supply Multikine for the Phase III clinical trial as well as commercial s
    '/>"/>

SOURCE CEL-SCI Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine
2. CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect
3. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
4. Data Suggest CEL-SCIs CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis
5. CEL-SCI Corporation Reports First Quarter Financial Results
6. CEL-SCI Corporation Announces 2007 Financial Results
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
8. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
9. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
10. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
11. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 2013 DST Health Solutions, LLC (DSTHS), a ... plans, integrated delivery systems, and health care providers, has ... Service (MDMS) has jumped significantly. A ... pricing of medical prescription drug claims, MDMS ... medical drug claims processes. As specialty drug demand grows ...
(Date:6/19/2013)... , June 19, 2013   Life Technologies ... a licensing agreement granting Suzhou Ribo Life Sciences ... siRNA therapeutics in China ... formulate proprietary siRNA molecules in combination with Invivofectamine® ... address human diseases with high unmet medical need ...
(Date:6/19/2013)... 19, 2013  It may seem like an odd pairing: ... cancer. But these were two of the most talked about ... Annual Meeting & Expo that just convened in ... focus by some of the top internal medicine experts in ... new research that can not only save lives, but help ...
Breaking Medicine Technology:Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 2Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 2"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 3"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 4
... Calif., Dec. 14, 2010 Samplify Systems, Inc., ... for the ultrasound market, is pleased to announce ... imaging has won Electronic Design Magazine,s ... medical category.  Details of Samplify,s AutoFocus™ beamforming technology ...
... VIVUS, Inc. (Nasdaq: VVUS ) today announced ... secure regulatory approval for QNEXA® in the U.S., submitted a ... to address items in the FDA,s Complete Response Letter (CRL), ... the Endocrine and Metabolic Division of the FDA has granted ...
Cached Medicine Technology:Samplify's AutoFocus™ Beamforming Technology Awarded Electronic Design's 'Best of 2010' 2VIVUS Submits Briefing Document to FDA, Announces Follow-up Meeting to Discuss QNEXA® 2VIVUS Submits Briefing Document to FDA, Announces Follow-up Meeting to Discuss QNEXA® 3
(Date:6/19/2013)... 19, 2013 The deadline to ... this Friday, June 21 at midnight ET. This ... and innovative people who’ve raised the bar on ... http://www.minonline.com/ima . , Any consumer and b2b ... is eligible to enter. Additionally, advertising agencies and ...
(Date:6/19/2013)... 19, 2013 Today, Zane Benefits, Inc. ... Exchange . Zane Benefits, which provides comprehensive and flexible ... leader in defined contribution and health ... website, as part of the Affordable Care Act (ACA), ... become available through new state health insurance exchanges. , ...
(Date:6/19/2013)... June 19, 2013 The Journal of ... with today’s computer software, it creates questions of ethics. ... misconduct. As an already published case shows, scientific publications ... , The Journal of Parasitology features a ... in a 2004 article published in the Journal of ...
(Date:6/19/2013)... The results of three important studies have been ... official journal of the Congress of Neurological Surgeons ... Williams & Wilkins , a part of Wolters ... "machine learning" using artificial neural networks (ANNs) may improve ... brain cancers. Another study in the June Neurosurgery ...
(Date:6/19/2013)... Philadelphia, PA (June 19, 2013) In early April, ... agencies met in Hartford, Connecticut, to discuss one question: ... casualty event? , The preliminary results of ... from Active Shooter Events: The Hartford Consensus ," a ... Journal of Trauma and Acute Care ...
Breaking Medicine News(10 mins):Health News:Entry Deadline for min’s Integrated Marketing Awards Is This Friday, June 21 2Health News:Zane Benefits Publishes New Information on the Wisconsin Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on the Wisconsin Health Insurance Exchange 3Health News:Altered Photo in Journal Article Illustrates the Need for Manipulation Guidelines 2Health News:Neurosurgery publishes findings of 3 important studies in June issue 2Health News:Neurosurgery publishes findings of 3 important studies in June issue 3Health News:Hartford consensus aims to improve survival after mass shootings 2
... 26 Authentidate Holding Corp. (Nasdaq: ... Information Exchange and workflow management services, announced today ... Parascript, LLC and Parascript Management, Inc. (collectively "Parascript") ... of Merger it entered into with Authentidate. The ...
... at the,Northwoods Cancer Center near Houston, Texas are ... from Varian Medical Systems,(NYSE: VAR ). ... cancer, is,among the first patients in Houston to ... delivers image-guided intensity-modulated radiation therapy,(IMRT) two to eight ...
... Decision Resources, Clinical Gold Standard for Crohn,s Disease ... Decision ResourcesWALTHAM, Mass., Jan. 26, ... and advisory firms for pharmaceutical and healthcare issues, ... effect on maintenance of clinical remission is the ...
... Biological Vascular Strips in the U.S. ... the Product Line--,VANCOUVER, Jan. 26 /PRNewswire-FirstCall/ - Neovasc Inc. ... announced that it has entered into a distribution agreement ... for Neovasc,s biological vascular strip for use in vascular ...
... help ORBIS train doctors in the treatment of retinal ... International , a nonprofit organization dedicated to saving sight ... of a new partnership with global ophthalmic company ... retinal diseases, PASCAL dramatically improves the physician,s ability to ...
... Trintech Group Plc (Nasdaq: TTPA ), ... risk management, and compliance solutions, today announced that the ... on January 27 in Mountain View, California as part ... common experiences, discuss the latest market trends and innovations ...
Cached Medicine News:Health News:Authentidate Announces Termination of Merger Agreement With Parascript, LLC 2Health News:Authentidate Announces Termination of Merger Agreement With Parascript, LLC 3Health News:A Fast, New Cancer Fighting Tool Is Now Available in the Houston Area: RapidArc(TM) Radiotherapy Technology from Varian Medical Systems 2Health News:A Fast, New Cancer Fighting Tool Is Now Available in the Houston Area: RapidArc(TM) Radiotherapy Technology from Varian Medical Systems 3Health News:Surveyed Gastroenterologists Indicate That Humira Has Advantages Over Remicade in Maintaining Clinical Remission of Crohn's Disease 2Health News:Surveyed Gastroenterologists Indicate That Humira Has Advantages Over Remicade in Maintaining Clinical Remission of Crohn's Disease 3Health News:Neovasc Announces Agreement With LeMaitre Vascular for Exclusive Distribution Rights to its Biological Vascular Strips 2Health News:Neovasc Announces Agreement With LeMaitre Vascular for Exclusive Distribution Rights to its Biological Vascular Strips 3Health News:ORBIS International Receives Donated PASCAL(R) Photocoagulator From OptiMedica 2Health News:ORBIS International Receives Donated PASCAL(R) Photocoagulator From OptiMedica 3Health News:ORBIS International Receives Donated PASCAL(R) Photocoagulator From OptiMedica 4Health News:KPMG and Trintech Collaborate to Enable Bay Area Users Group of Trintech Customers to Optimize Their Investments in Technology and Deliver Improved Performance in Turbulent Economic Times 2Health News:KPMG and Trintech Collaborate to Enable Bay Area Users Group of Trintech Customers to Optimize Their Investments in Technology and Deliver Improved Performance in Turbulent Economic Times 3
... Compact Sigma is designed to easily ... precise mechanical coupling eliminates clumsy time ... performed as well. Dorniers patented isocentric ... ,Positioning is simple using the Dornier ...
Used for temporary control of male urinary incontinence due to surgery or neurogenic disorder. Supplied non-sterile. Reusable. Intended for single patient use only....
... ideally suited for high volume stone centers. This ... and an advanced urological table. With the Dornier ... provides successful treatments for a full range of ... URS and PCN procedures are easy. One of ...
Used for male external catheterization due to urinary incontinence. The inflatable retention ring secures the catheter and can be easily deflated for removal. Supplied non-sterile. Reusable. Intended...
Medicine Products: